FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Verastem's Free Cash Flow for the
three
months ended in Dec. 2024 was $-25.10 Mil. Verastem's Revenue for the
three
months ended in Dec. 2024 was $0.00 Mil. Therefore, Verastem's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.
The historical rank and industry rank for Verastem's FCF Margin % or its related term are showing as below:
VSTM'
s FCF Margin % Range Over the Past 10 Years
Min: -2615.59 Med: -920.78 Max: -37.89
Current: -1047.99
During the past 13 years, the highest FCF Margin % of Verastem was -37.89%. The lowest was -2615.59%. And the median was -920.78%.
VSTM's FCF Margin % is ranked worse than 77.78% of 1008
companies
in the Biotechnology industry
Industry Median: -129.705
vs VSTM: -1047.99
Verastem FCF Margin % Historical Data
The historical data trend for Verastem's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Verastem's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Verastem's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Verastem's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Verastem's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Verastem FCF Margin % Related Terms
Thank you for viewing the detailed overview of Verastem's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VSTM has been successfully added to your 